Results 11 to 20 of about 29,812 (199)
Introduction The aim of the study was to explore the clinical efficacy and safety of intravenous thrombolysis and bridging artery thrombectomy for hyperacute ischemic stroke with unknown onset time.
Bai Qingke +3 more
doaj +1 more source
Cerebral hemodynamics in stroke thrombolysis (CHiST) study.
Despite careful patient selection, successful recanalization in intravenous thrombolysis is only achieved in approximately 50% of cases. Understanding changes in cerebral autoregulation during and following successful recanalization in acute ischemic ...
Man Y Lam +3 more
doaj +1 more source
Objective To explore the relationship between regional leptomeningeal collateral (rLMC) score, peripheral blood angiotensin-converting enzyme (ACE), matrix-derived growth factor (SDF)-1α levels, and the prognosis of acute anterior circulation ischemic ...
LI Binglong*, GAO Xia, LI Yan
doaj +1 more source
Objective To screen the related influencing factors of prognosis in acute anterior ischemic stroke patients who underwent intravenous thrombolysis, and to explore the predictive ability of two collateral scores based on CT angiography (CTA).
Yan CHEN, Jia-ju ZHAO, Bo WU
doaj +1 more source
Repeated intravenous thrombolysis in early recurrent stroke secondary to carotid web: Case report
Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the first effective approved treatment for reducing ischemic stroke disability, and having a stroke within 3 months is usually a contraindication to thrombolysis.
Siham Bouchal, PhD +4 more
doaj +1 more source
Context: Application of anti-clot drugs such as recombinant tissue plasminogen activator (rt-PA) to treat patients with strokes is considered as a standard treatment employed through two techniques: intra-arterial and intravenous thrombolysis.
Mojtaba Nouhi +4 more
doaj +1 more source
Gait and Balance Disorder in Patients with Transient Ischemic Attack or Minor Stroke [Corrigendum]
Li N, Li J, Gao T, Wang D, Du Y, Zhao X. Neuropsychiatr Dis Treat. 2021;17:305–314. The authors have advised that the r value of intravenous thrombolysis in correlation with the Tandem scale in Table 4 and Table S2 is incorrect.
Li N, Li J, Gao T, Wang D, Du Y, Zhao X
doaj
Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke [PDF]
Background and Purpose— Demographic changes will result in a rapid increase of patients age ≥90 years (nonagenarians), but little is known about outcomes in these patients after intravenous thrombolysis (IVT) for acute ischemic stroke.
Sarikaya, Hakan +13 more
openaire +5 more sources
Background and Purpose: Cardiac myxoma is a rare etiology of stroke. Both cerebral microbleeds and cardiac myxoma may increase the risk of intracerebral hemorrhage after intravenous thrombolysis. However, data is still limited.
Aurauma eChutinet +6 more
doaj +1 more source
Time cost of a nonclosing intravenous thrombolysis service for acute ischemic stroke
Background/Purpose: Intravenous thrombolysis for ischemic stroke saves societal costs. The aim of this study was to investigate the cost burden that hospitals may shoulder.
Mu-Chien Sun, Pi-Ju Hsiao
doaj +1 more source

